5/8/2013

Older patients with myelodysplastic syndromes who received transplants of stem cells from younger matched but unrelated donors had fewer relapses and better five-year survival rates than patients who received cells from siblings or older matched but unrelated donors, according to a study in the journal Leukemia. The researchers reviewed the cases of 719 transplant recipients in Europe from 1999 to 2008.

Full Story:
MDSBeacon.com

Related Summaries